Sun Pharma Advanced Research Company Limited Share Price and Company Fundamentals
Last traded: Today at 9:59 AM
Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology and immunology. The company is also developing Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia that is in phase 2 clinical trial; and Vibozilimod (SCD-044), a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial. In addition, it develops SCD-153 for the treatment of alopecia areata; and SBO-154, an anti-MUC-1 ADC, for the treatment of multiple tumors that is in preclinical trials. The company was incorporated in 2006 and is based in Mumbai, India.
Key Metrics
PE ratio
-
PB ratio
-
Dividend yield
-
Beta
0.13
Market cap
₹41.38B
Enterprise value
₹45.50B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 316 |
| Website | https://sparc.life |
| Mailing address | 17/B, Mahal Industrial Estate Off Mahakali Caves Road Andheri (East) Mumbai 400093 India |
| Phone / Fax | 91 22 6645 5645 / 91 22 6645 5685 |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
0.00%
5Y Avg. yield
-%
Sun Pharma Advanced Research Company Limited paid ₹- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.SPARC dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Sun Pharma Advanced Research Company Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Anilkumar Raghavan | Chief Executive Officer | 57 | |
| Mr. Anup Rathi | Chief Financial Officer | ||
| Dr. Nitin Dharmadhikari | Chief Operating Officer | 63 | |
| Mr. Jaydeep Issrani | Senior General Manager of Business Development, Corporate Communication & Investor Relations | ||
| Ms. Kajal K. Damania | Company Secretary & Compliance Officer | ||
| Ms. Shanta Gupta | Chief Human Resource Officer | ||
| Mr. Siu-Long Yao | Head Clinical Development | ||
| Dr. Nitin K. Damle Ph.D. | Executive VP of Biologics & Chief Innovation Officer | ||
| Dr. Yashoraj Zala | Head of Drug Delivery Systems | ||
| Dr. Vikram K. Ramanathan | Head of Drug Discovery & Preclinical Development |
Profitability and management effectiveness
Profit margin
0.00%
Operating margin
-700.71%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Sun Pharma Advanced Research Company Limited is 41.38B and its enterprise value is 45.50B. The enterprise value to revenue ratio of SPARC is 85.63. The enterprise value to EBITDA ratio of SPARC is -19.92.
The SPARC's stocks Beta value is 0.13 making it 87% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Sun Pharma Advanced Research Company Limited (NSE:SPARC) Frequently Asked Questions
1. What is Sun Pharma Advanced Research Company Limited's Stock Symbol?
Sun Pharma Advanced Research Company Limited trades on NSE under the ticker symbol "SPARC".
2. What is Sun Pharma Advanced Research Company Limited's stock price today?
One share of SPARC stock can currently be purchased for approximately ₹127.5.
3. How can I contact Sun Pharma Advanced Research Company Limited?
Sun Pharma Advanced Research Company Limited's mailing address is 17/B, Mahal Industrial Estate Off Mahakali Caves Road Andheri (East) Mumbai 400093 India. The company can be reached via phone at 91 22 6645 5645.
4. What is Sun Pharma Advanced Research Company Limited's official website?
The official website of Sun Pharma Advanced Research Company Limited is https://sparc.life.